or Try an Advanced Search...

    Technical Analysis for ADAG - Adagene Inc.

    Grade Last Price % Change Price Change
    D 2.18 -2.92% -0.07
    ADAG closed down 2.92 percent on Wednesday, May 8, 2024, on 8.89 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical ADAG trend table...
    Date Alert Name Type % Chg
    Volume Surge Other 0.00%
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Gapped Down Weakness 0.00%
    200 DMA Support Bullish -2.92%
    Wide Bands Range Expansion -2.92%
    Lower Bollinger Band Touch Weakness -2.92%
    Wide Bands Range Expansion -5.63%
    Older End-of-Day Signals for ADAG ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 18 hours ago
    Possible Inside Day about 18 hours ago
    2x Volume Pace about 18 hours ago
    1.5x Volume Pace about 18 hours ago
    3x Volume Pace about 18 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ADAG Chart by TradingView
    Basic chart:

    Profile

    Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Its proprietary pipeline is comprised of novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Artificial Intelligence Immunology Immunotherapy Antibodies Health Care Cancer Immunotherapy Antibody Virotherapy Immunotherapies

    Is ADAG a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 29 Adagene ADR Non-GAAP EPS of -$0.21, revenue of $18.11M
    Mar 29 Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
    Mar 7 Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board
    Feb 27 Adagene to Present at the Leerink Partners Global Biopharma Conference 2024
    Feb 9 Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with KEYTRUDA® (pembrolizumab) to Demonstrate Further Efficacy in Patients with Metastatic Microsatellite-st...
    Jan 19 Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Jan 18 How Is The Market Feeling About Adagene?
    Jan 17 Adagene falls after trial data for cancer therapy
    Jan 17 Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket
    Jan 16 Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
    See more ADAG news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.38
    52 Week Low 1.1001
    Average Volume 22,246
    200-Day Moving Average 2.11
    50-Day Moving Average 2.73
    20-Day Moving Average 2.49
    10-Day Moving Average 2.31
    Average True Range 0.24
    RSI (14) 36.31
    ADX 23.34
    +DI 11.35
    -DI 22.50
    Chandelier Exit (Long, 3 ATRs) 2.41
    Chandelier Exit (Short, 3 ATRs) 2.79
    Upper Bollinger Bands 2.88
    Lower Bollinger Band 2.10
    Percent B (%b) 0.1
    BandWidth 31.15
    MACD Line -0.15
    MACD Signal Line -0.13
    MACD Histogram -0.0192
    Fundamentals Value
    Market Cap 95.56 Million
    Num Shares 43.8 Million
    EPS -0.86
    Price-to-Earnings (P/E) Ratio -2.53
    Price-to-Sales 6.89
    Price-to-Book 1.85
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.37
    Resistance 3 (R3) 2.37 2.31 2.33
    Resistance 2 (R2) 2.31 2.26 2.31 2.32
    Resistance 1 (R1) 2.24 2.23 2.28 2.24 2.31
    Pivot Point 2.19 2.19 2.20 2.18 2.19
    Support 1 (S1) 2.12 2.14 2.15 2.12 2.05
    Support 2 (S2) 2.06 2.11 2.06 2.04
    Support 3 (S3) 2.00 2.06 2.03
    Support 4 (S4) 1.99